Skip to content
‹ Back to IndustriesSciences

Myrias Optics taps photonics veteran Neil Anderson as CRO to scale flat optics into AI datacenters and AR

Myrias Optics has hired Neil Anderson, Ph.D. as the Chief Revenue Officer to spearhead the commercialization of its nanoimprint flat optics platform. The platform is intended for use in AI datacenters, augmented reality (AR), and life sciences applications. Anderson's experience in photonics is expected to aid Myrias Optics in expanding its market presence in these sectors.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By MarketScale Newsroom · Myrias OpticsMetaopticsFlat OpticsPhotonics
Share
Listen to the audio brief

Key facts, context, and what it means.

AUDIO
0:00—
Myrias Optics taps photonics veteran Neil Anderson as CRO to scale flat optics into AI datacenters and AR

Key takeaways

01

Myrias Optics appointed Neil Anderson, Ph.D. as CRO to lead the commercialization of its technology.

02

The company focuses on nanoimprint flat optics for AI datacenters, AR, and life sciences.

03

Neil Anderson brings extensive photonics expertise to support Myrias Optics' growth.

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Myrias Optics named Neil Anderson, Ph.D. as its new Chief Revenue Officer on July 22, bringing a 15-year track record in photonics commercialization to a company positioning its wafer-level flat optics platform for volume production across AI infrastructure, augmented reality, and life sciences. The Amherst, Massachusetts company announced the hire via PR Newswire, citing Anderson's history of converting deep-tech optical products into scalable, market-leading businesses at Gooch & Housego, quantum startup Infleqtion, and IDEX Corporation.

Anderson's scope at Myrias covers global sales, business development, marketing, strategic partnerships, and commercial operations, essentially every function between the laboratory and a signed purchase order. The appointment signals that Myrias is moving from technology validation into aggressive market capture, a shift that will matter to procurement and engineering teams evaluating optical component suppliers in several fast-moving verticals.

A manufacturing platform built for volume, not just prototypes

Myrias' central asset is its all-inorganic nanoimprint lithography process, which produces metaoptics and diffractive optical elements at the wafer level. According to the company, the platform combines industry-leading material performance with strong yield characteristics and a clear path to production-scale deployment, attributes that matter directly to supply chain leaders trying to qualify new optical components without absorbing yield-driven cost surprises.

Conventional optics manufacturing often struggles to keep pace with the volume demands of AI datacenter buildouts and the tight form-factor requirements of AR headsets. Wafer-level production addresses both constraints by treating optical elements more like semiconductor components, enabling tighter tolerances and higher throughput than traditional glass-grinding or injection-molding approaches. Myrias' inorganic material choice also offers thermal and environmental durability advantages relevant to datacenter and industrial deployments.

Wafer-level flat optics production is increasingly a sourcing variable, not just a technology curiosity, and Myrias is now staffing for volume.

The company's commercial traction appears to back that framing. A separate PR Newswire release from Myrias noted more than 25 customer engagements across AR, datacom, and consumer electronics, a pipeline that suggests enterprise buyers are already evaluating the platform for near-term programs, not just long-range roadmap conversations.

Anderson's background spans the markets Myrias is targeting

Anderson holds a Ph.D. in optical science and engineering from the University of Rochester's Institute of Optics and a master's degree in physics, according to PR Newswire. That technical grounding has been central to his career model: building trust with engineering and procurement counterparts at complex enterprise accounts before converting that credibility into commercial wins.

At Gooch & Housego, a precision photonics manufacturer serving aerospace, defense, and industrial markets, Anderson led commercial teams responsible for global growth. His time at Infleqtion, a quantum technology startup, added experience translating early-stage science into structured go-to-market programs. At IDEX Corporation, a diversified industrial manufacturer with significant optical and photonic business units, he managed enterprise partnerships with Fortune 1000 accounts across semiconductor, medical diagnostics, and datacom verticals, according to both the Myrias website and the PR Newswire announcement.

That cross-vertical résumé maps almost exactly onto the end markets Myrias is chasing: AI datacenters need high-volume optical interconnect components, AR device makers need manufacturable waveguide solutions, and life sciences customers need precision imaging optics that can pass regulatory scrutiny. Anderson has sold into all three.

What the hire means for teams evaluating optical component suppliers

CEO John Fijol, in remarks reported by both Myrias and PR Newswire, framed the appointment around scale: Anderson's ability to build enduring partnerships with global enterprise companies will be critical as Myrias expands manufacturing capacity. That language matters to procurement directors assessing supplier readiness. A company adding CRO-level commercial infrastructure is typically preparing to support larger program commitments, longer-term supply agreements, qualified-supplier status processes, and dedicated account management.

Anderson, in his own remarks published in the same release, described Myrias' manufacturing approach as redefining how AR waveguide and meta optics are produced at scale, and pointed to the company's ambition to establish market leadership in high-volume flat optics. For engineering and supply chain teams at AR hardware companies or datacenter optical module vendors, that positioning is worth tracking now, before design-win windows close on next-generation platform programs.

Myrias currently operates from Amherst, Massachusetts. With more than 25 active customer engagements already confirmed across key verticals, the CRO hire is the next step in converting that pipeline into production-stage contracts.

Featured companies

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

MarketScale Newsroom
MarketScale NewsroomEditorial Team, MarketScale

The MarketScale Newsroom reports on the companies, technologies, and trends shaping 16 B2B industries. It turns primary sources and expert commentary into clear, useful coverage for the people doing the work.

B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

UCB commits to Veeva Vault CRM for unified engagement

UCB commits to Veeva Vault CRM for unified engagement

UCB has committed to Veeva Vault CRM, which Veeva's release presents as an agentic CRM platform to drive unified engagement worldwide. Executives from both companies describe it as a foundation for commercial execution, while the AI claims, including the Agentic Call Report, come from Veeva's product description. No go-live date or financial terms were given.

  • 01The executive statements focus on Vault CRM as a foundation. The AI pitch, including the Agentic Call Report, comes from Veeva’s product description.
  • 02Veeva says the Agentic Call Report turns field call records into "Commercial Evidence" about treatment barriers that went unseen before. If that works, call-report data becomes something UCB can analyze.
  • 03Neither company disclosed a go-live date or financial terms. The first rollout milestone UCB names will be the signal that the move is actually happening.

Nov 7, 2026

Why ISPE put peptide and oligo facility design in one guide

Why ISPE put peptide and oligo facility design in one guide

ISPE's new Baseline Guide covers oligonucleotide and peptide facility design in one document, says Jim Love of CRB. It pairs a GMP survey of existing plants with a sustainability outlook and a piping safety framework for scale-up, while FDA's oligonucleotide guidances under dockets opened in 2022 and 2024 remain the regulator's own reference.

  • 01Peptide plants inherited API chemistry thinking and oligo plants biotech thinking; ISPE’s guide puts both modalities in one facility document with both inheritances.
  • 02The guide has three parts: a GMP survey of existing oligo and peptide plants, a forecast of how sustainability and scale will change the processes, and a safety framework for connective piping and equipment.
  • 03FDA keeps its own oligonucleotide-specific guidances under dockets opened in 2022 and 2024, so the ISPE guide works as an industry consensus alongside regulation rather than in place of it.

Nov 5, 2026

Collagen builder Astrion outdrew AstraGin at NuLiv's Bangkok booth

Collagen builder Astrion outdrew AstraGin at NuLiv's Bangkok booth

NuLiv Science says Astrion, its collagen-building ingredient, drew more interest than AstraGin at Vitafoods Asia 2026 in Bangkok, held September 2 to 4. Brands also asked for probiotic strains for pet weight loss, children, and women's health. New trials for AstraGin in Nutrients and Senactiv provide updated evidence for these distinct ingredients.

  • 01At Vitafoods Asia 2026 in Bangkok, Astrion drew more booth interest than AstraGin, NuLiv’s absorption flagship.
  • 02NuLiv says probiotic requests are now split by pet, child and life stage, and the show preview lists strains for women’s health, emotional wellbeing and the gut-muscle axis.
  • 03A newly published crossover trial in Nutrients found AstraGin raised branched-chain amino acid absorption and grip strength in adults aged 60 to 80.

Nov 5, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Experts

MarketScale Newsroom
MarketScale Newsroom

Editorial Team

MarketScale

The MarketScale Newsroom reports on the companies, technologies, and trends shaping 16 B2B industries. It turns primary sources and expert commentary into clear, useful coverage for the people doing the work.

NA
Neil Anderson

CRO

Myrias Optics

Neil Anderson, Ph.D., joins Myrias Optics as Chief Revenue Officer to drive the commercialization of its nanoimprint flat optics platform across AI datacenters, augmented reality, and life sciences.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512